Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug shows promise for tough head and neck cancers

NCT ID NCT05271604

Completed Disease control Sponsor: BioAtla, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called ozuriftamab vedotin in 42 people with head and neck cancer that returned or spread. The goal was to see if the drug could shrink tumors and to check for side effects. Participants received the drug alone or with other treatments, and researchers measured how many responded and how long the benefit lasted.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma metastatic malignant neoplasm metastatic squamous cell carcinoma neoplasm Neoplasm Metastasis Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK CANCER METASTATIC CANCER METASTATIC SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK RECURRENT SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK SQUAMOUS CELL CARCINOMA OF HEAD AND NECK

Contacts and locations

Locations

  • Christiana Care Helen Graham Cancer Center

    Newark, Delaware, 19713, United States

  • Huntsman Cancer Institute

    Salt Lake City, Utah, 84112, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, 10065, United States

  • Northwestern University

    Chicago, Illinois, 60611, United States

  • Norton Cancer Institute

    Louisville, Kentucky, 40202, United States

  • USC Norris Comprehensive Cancer Center

    Los Angeles, California, 90033, United States

  • Washington University Medical Siteman Cancer Center

    St Louis, Missouri, 63110, United States